A
$ Value
—
Shares
2,693
Price
—
Filed
Jul 25
Insider
Name
KROLL MARK W
Title
—
CIK
0001259254
Roles
Director
Transaction Details
Transaction Date
2025-07-24
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
23,357
Footnotes
The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant. | Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
Filing Info
Other Insiders at HAE (90d)
No other insider activity at this issuer in the last 90 days.